Jasper Therapeutics, Inc.
JSPRW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001788028
No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $187.1K in total; no superinvestor holds it.
Other share classesJSPR
Q2 2022 vs. Q1 2022
How the institutions holding Jasper Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 16 | 15 | −1 |
| Shares | 1.43M | 1.45M | +12.4K (+0.9%) |
| Value | $554.0K | $179.0K | −$375.0K (−67.7%) |
New holders (1)
Institutions that held Jasper Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cowen and Company, LLC | 32,590 | $3.00K | 0.00% |
Sold out (2)
Institutions that held Jasper Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Yakira Capital Management, Inc. | 11,705 | $4.00K |
| Integrity Capital Management (HK) Ltd | 5,439 | $2.00K |